Dr. Christine Desbiens is a surgeon-oncologist at the CHU de Québec-Laval University. She is also a clinical researcher at the Research Center of the CHU de Québec-Université Laval and clinical professor at the Faculty of Medicine of Laval University. Dr. Desbiens is part of the research group of the Centre des Maladies du Sein of CHU de Québec-Laval University.
Dr. Desbiens is the leader of the Canadian Clinical Trial Group at Saint-Sacrement Hospital of the CHU de Québec. She is also the medical director for the Centre des Maladies du Sein du CHU de Québec.
Using structured breast cancer data
The Centre des Maladies du Sein research team has a comprehensive database of all cancers diagnosed since 1974; more than 12,000 patients are listed. A database of biopsy data from 1999 is also available; data on more than 34,000 biopsies are listed. These databases allow quality publications that modify the management and management of cancers and benign breast diseases.
Offer innovative treatments
The research group of the Centre des Maladies du Sein of the CHU de Québec-Laval University is one of the largest research groups in Canada offering innovative treatments for breast cancer. More than 50 clinical trials are active at all times, and are offered to patients who consult at the clinic or are referred by clinics/hospitals in the area. These clinical trials provide access to innovative experimental medications and develop the expertise of our world-renowned oncologists.
Support the quality of life
The Centre des Maladies du Sein of the CHU de Québec-Laval University research group is a pioneer in quality of life studies in breast cancer, from total mastectomy to partial mastectomy, to the use of the cooling cap to counteract hair loss, promoting physical activity to improve survivorship, including optimal preservation of the axillary lymph nodes. The research group is at the forefront of studies promoting quality of life, despite the disease’s life trial.
1050, chemin Sainte-Foy
Centre des maladies du sein Deschênes-Fabia
Canada G1S 4L8
Data not available
Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsyJournal Article
Anticancer Res, 34 (3), 2014.
[Multidisciplinary clinical management for prophylactic mastectomy: views of women from one centre in Quebec City]Journal Article
Bull Cancer, 100 (3), 2013.
Self-reported mammography use following BRCA1/2 genetic testing may be overestimatedJournal Article
Fam Cancer, 11 (1), 2012.
Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsyJournal Article
Radiology, 263 (1), 2012.
Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollmentJournal Article
Clin Trials, 9 (5), 2012.
Primary breast angiosarcoma: avoiding a common trapBook
Primary breast angiosarcoma: avoiding a common trapJournal Article
Case Rep Oncol Med, 2011 , 2011.
Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsyJournal Article
Breast, 20 (1), 2011.
Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-upJournal Article
Breast Cancer Res Treat, 128 (2), 2011.
- Exploring the impact for COVID-19 pandemic on women with breast cancer in Quebec, from 2021-12-01 to 2023-09-30
- NSABP Breast Cancer Treatment Protocols, from 1997-02-01 to 2025-12-25
- Vers des trajectoires de soins en cancer du sein personnalisées en fonction du risque et des besoins des patientes: une étude de faisabilité et d'acceptabilité, from 2023-04-01 to 2025-03-31
Recently finished projects
- Tomosynthesis Mammographic Imaging Screening Trial (TMIST), from 2017-09-11 to 2022-12-25